Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone as Add-On Therapy to Imatinib in CML
NCT02888964Phase 2Completed
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Dec 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in chronic myeloid leukemia (CML), sponsored by Centre Hospitalier de Versailles. Started Dec 2009; status: completed.
02
Drugs
pioglitazone
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02888964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02888964.